Literature DB >> 24210116

Coding potential of UL/b' from the initial source of rhesus cytomegalovirus Strain 68-1.

Rachel B Gill1, J Jason Bowman, Tammy Krogmann, Kurt Wollenberg, David M Asher, Jeffrey I Cohen.   

Abstract

Rhesus cytomegalovirus (RhCMV) 68-1 is the prototypic strain of RhCMV that has been used for pathogenesis and vaccine development. We determined the complete sequence of the RhCMV 68-1 UL/b' region directly from the original urine from which RhCMV 68-1 was isolated in 1968, and compared it to other RhCMVs. The laboratory passaged RhCMV 68-1 has inversions, deletions, and stop codons in UL/b' that are absent in the original isolate and other low passage RhCMV isolates. Fourteen of the 17 open reading frames (ORFs) in 68-1 UL/b' in the original isolate share >95% amino acid identity with low passage RhCMV. The original isolate retains 6 ORFs that encode α-chemokine-like proteins, including RhUL146 and RhUL146b that share only 92% and 81% amino acid identity, respectively, with a contemporary low passage RhCMV isolate. Identification of the original RhCMV 68-1 UL/b' sequence is important for using RhCMV 68-1 in pathogenesis and vaccine studies.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cercopithecine herpesvirus: macacine herpesvirus 3; Cynomolgus macaque cytomegalovirus; Human cytomegalovirus; Rhesus cytomegalovirus; UL/b′

Mesh:

Substances:

Year:  2013        PMID: 24210116      PMCID: PMC4791096          DOI: 10.1016/j.virol.2013.08.026

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  39 in total

1.  The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist.

Authors:  Hans R Lüttichau
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

2.  Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004.

Authors:  Sheri Lewis Bate; Sheila C Dollard; Michael J Cannon
Journal:  Clin Infect Dis       Date:  2010-06-01       Impact factor: 9.079

3.  Open reading frames carried on UL/b' are implicated in shedding and horizontal transmission of rhesus cytomegalovirus in rhesus monkeys.

Authors:  Kristie L Oxford; Lisa Strelow; Yujuan Yue; W L William Chang; Kimberli A Schmidt; Don J Diamond; Peter A Barry
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

Review 4.  The role of chemokines in neutrophil biology.

Authors:  Yoshiro Kobayashi
Journal:  Front Biosci       Date:  2008-01-01

Review 5.  Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications.

Authors:  M Grazia Revello; Giuseppe Gerna
Journal:  Rev Med Virol       Date:  2010-05       Impact factor: 6.989

6.  Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.

Authors:  Annalisa Macagno; Nadia L Bernasconi; Fabrizia Vanzetta; Erica Dander; Antonella Sarasini; Maria Grazia Revello; Giuseppe Gerna; Federica Sallusto; Antonio Lanzavecchia
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

Review 7.  Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus.

Authors:  Yujuan Yue; Peter A Barry
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

8.  Protein coding content of the UL)b' region of wild-type rhesus cytomegalovirus.

Authors:  Kristie L Oxford; Meghan K Eberhardt; Kai-Wen Yang; Lisa Strelow; Suzanne Kelly; Shan-Shan Zhou; Peter A Barry
Journal:  Virology       Date:  2008-02-20       Impact factor: 3.616

9.  Patterns of divergence in the vCXCL and vGPCR gene clusters in primate cytomegalovirus genomes.

Authors:  Donald J Alcendor; Jianchao Zong; Aidan Dolan; Derek Gatherer; Andrew J Davison; Gary S Hayward
Journal:  Virology       Date:  2009-10-09       Impact factor: 3.616

10.  Efficient replication of rhesus cytomegalovirus variants in multiple rhesus and human cell types.

Authors:  Anders E Lilja; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-08       Impact factor: 11.205

View more
  6 in total

Review 1.  CD8+ T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccination.

Authors:  Klaus Früh; Louis Picker
Journal:  Curr Opin Immunol       Date:  2017-07-19       Impact factor: 7.486

2.  Pathogenesis of Wild-Type-Like Rhesus Cytomegalovirus Strains following Oral Exposure of Immune-Competent Rhesus Macaques.

Authors:  Yujuan Yue; W L William Chang; Julia Li; Nancy Nguyen; Kimberli A Schmidt; Philip R Dormitzer; Xinzhen Yang; Peter A Barry
Journal:  J Virol       Date:  2021-11-17       Impact factor: 6.549

3.  Cytomegaloviral determinants of CD8+ T cell programming and RhCMV/SIV vaccine efficacy.

Authors:  Daniel Malouli; Scott G Hansen; Meaghan H Hancock; Colette M Hughes; Julia C Ford; Roxanne M Gilbride; Abigail B Ventura; David Morrow; Kurt T Randall; Husam Taher; Luke S Uebelhoer; Matthew R McArdle; Courtney R Papen; Renee Espinosa Trethewy; Kelli Oswald; Rebecca Shoemaker; Brian Berkemeier; William J Bosche; Michael Hull; Justin M Greene; Michael K Axthelm; Jason Shao; Paul T Edlefsen; Finn Grey; Jay A Nelson; Jeffrey D Lifson; Daniel Streblow; Jonah B Sacha; Klaus Früh; Louis J Picker
Journal:  Sci Immunol       Date:  2021-03-25

4.  In vitro and in vivo characterization of a recombinant rhesus cytomegalovirus containing a complete genome.

Authors:  Husam Taher; Eisa Mahyari; Craig Kreklywich; Luke S Uebelhoer; Matthew R McArdle; Matilda J Moström; Amruta Bhusari; Michael Nekorchuk; Xiaofei E; Travis Whitmer; Elizabeth A Scheef; Lesli M Sprehe; Dawn L Roberts; Colette M Hughes; Kerianne A Jackson; Andrea N Selseth; Abigail B Ventura; Hillary C Cleveland-Rubeor; Yujuan Yue; Kimberli A Schmidt; Jason Shao; Paul T Edlefsen; Jeremy Smedley; Timothy F Kowalik; Richard J Stanton; Michael K Axthelm; Jacob D Estes; Scott G Hansen; Amitinder Kaur; Peter A Barry; Benjamin N Bimber; Louis J Picker; Daniel N Streblow; Klaus Früh; Daniel Malouli
Journal:  PLoS Pathog       Date:  2020-11-24       Impact factor: 7.464

5.  RhCMV serostatus and vaccine adjuvant impact immunogenicity of RhCMV/SIV vaccines.

Authors:  W L William Chang; Jesse D Deere; Hung T Kieu; Luis D Castillo; Kawthar Machmach; Xiaoying Shen; Georgia D Tomaras; Barbara L Shacklett; Peter A Barry; Dennis J Hartigan-O'Connor; Ellen E Sparger
Journal:  Sci Rep       Date:  2020-08-20       Impact factor: 4.379

6.  Cross-Species Rhesus Cytomegalovirus Infection of Cynomolgus Macaques.

Authors:  Benjamin J Burwitz; Daniel Malouli; Benjamin N Bimber; Jason S Reed; Abigail B Ventura; Meaghan H Hancock; Luke S Uebelhoer; Amruta Bhusari; Katherine B Hammond; Renee G Espinosa Trethewy; Alex Klug; Alfred W Legasse; Michael K Axthelm; Jay A Nelson; Byung S Park; Daniel N Streblow; Scott G Hansen; Louis J Picker; Klaus Früh; Jonah B Sacha
Journal:  PLoS Pathog       Date:  2016-11-09       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.